Secure Your CRISPR Pipeline with Scalable cGMP Guide RNA

Join us for an exclusive webinar on GenScript’s cGMP Guide RNA Manufacturing Services and discover how we can help accelerate your CRISPR-based therapeutic development. As a trusted partner in cell and gene therapy, GenScript provides high-quality, scalable, and regulatory-compliant synthetic guide RNA (gRNA) for a variety of CRISPR systems, including Cas9, Cas12a, prime editing, and base editing.

Key Learning Objectives

Learn about GenScript’s cGMP guide RNA manufacturing capabilities and quality control processes.

Learn about the range of gene editing approaches that GenScript can support with cGMP gRNA services.

Understand how GenScript’s documentation support simplifies IND submissions and regulatory approvals.

Learn why procuring RUO to cGMP GRNA from a single vendor streamlines and de-risks the development process for CRISPR therapies.

In this webinar, learn more on

Webinar Details

  • Date: April 8th 2025
  • Time: 11:00 EST / 08:00 PST/ 16:00 GMT / 17:00 CET
  • Speaker:
Dr. Pedro Teh Dr. Pedro Teh

Sr. Global Product Manager
GenScript Biotech Corporation

Dr. Pedro (Jing Tsong) Teh is a Senior Global Product Manager of gene editing solutions at GenScript. He earned his Ph.D. in Molecular Biology from Ludwig Maximilian University of Munich (LMU). Dr. Teh has more than 10 years’ experience in cancer & stem cell research and technical support, with previous roles at DUKE-NUS and BGI Research. His current role at GenScript focuses on marketing and business strategy planning for their end-to-end gene editing services.

Speaker-related Webinars